X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (39) 39
adult (18) 18
female (17) 17
middle aged (16) 16
aged (14) 14
male (14) 14
neoplasms - drug therapy (12) 12
drug evaluation (9) 9
cancer (8) 8
oncology (8) 8
adolescent (7) 7
bone marrow - drug effects (7) 7
drug administration schedule (7) 7
drug therapy, combination (7) 7
thrombocytopenia - chemically induced (7) 7
leukopenia - chemically induced (6) 6
methotrexate - therapeutic use (6) 6
antineoplastic agents - adverse effects (5) 5
dose-response relationship, drug (5) 5
leukocyte count (5) 5
neoplasm metastasis (5) 5
time factors (5) 5
adenocarcinoma - drug therapy (4) 4
antineoplastic agents - administration & dosage (4) 4
breast (4) 4
clinical trials as topic (4) 4
injections, intravenous (4) 4
leukemia (4) 4
multiple myeloma - drug therapy (4) 4
prednisone - therapeutic use (4) 4
remission, spontaneous (4) 4
vincristine - therapeutic use (4) 4
animals (3) 3
blood cell count (3) 3
bone marrow cells (3) 3
breast neoplasms - surgery (3) 3
carcinoma, squamous cell - drug therapy (3) 3
central nervous system - drug effects (3) 3
child (3) 3
child, preschool (3) 3
cyclophosphamide - therapeutic use (3) 3
follow-up studies (3) 3
infusions, parenteral (3) 3
leukemia - drug therapy (3) 3
lymphatic metastasis (3) 3
lymphoma - drug therapy (3) 3
medicine, general & internal (3) 3
melphalan - administration & dosage (3) 3
melphalan - therapeutic use (3) 3
menopause (3) 3
neoplasms - therapy (3) 3
pancreatic neoplasms - drug therapy (3) 3
pharmacology & pharmacy (3) 3
prognosis (3) 3
streptozocin - administration & dosage (3) 3
streptozocin - adverse effects (3) 3
therapy (3) 3
age factors (2) 2
antineoplastic agents - therapeutic use (2) 2
bleomycin - administration & dosage (2) 2
bleomycin - therapeutic use (2) 2
blood platelets (2) 2
bone marrow - radiation effects (2) 2
breast neoplasms - drug therapy (2) 2
carmustine - adverse effects (2) 2
carmustine - therapeutic use (2) 2
castration (2) 2
cells, cultured (2) 2
colony-forming units assay (2) 2
combined modality therapy (2) 2
cyclophosphamide - administration & dosage (2) 2
cáncer (2) 2
drug synergism (2) 2
evaluation studies as topic (2) 2
fluorouracil - therapeutic use (2) 2
half-life (2) 2
hodgkin disease (2) 2
hodgkin disease - drug therapy (2) 2
in vitro techniques (2) 2
injections, intramuscular (2) 2
kinetics (2) 2
leukemia, lymphoid - drug therapy (2) 2
leukemia, myeloid - blood (2) 2
leukemia, myeloid - drug therapy (2) 2
liver neoplasms - drug therapy (2) 2
lung neoplasms - drug therapy (2) 2
lymphoma (2) 2
lymphoma, non-hodgkin (2) 2
mastectomy (2) 2
medicine (2) 2
medicine & public health (2) 2
medicine, research & experimental (2) 2
melphalan - adverse effects (2) 2
mercaptopurine - therapeutic use (2) 2
methods (2) 2
methotrexate - blood (2) 2
methotrexate - urine (2) 2
mice (2) 2
nausea - chemically induced (2) 2
neoplasm recurrence, local - drug therapy (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1986, Current treatment of cancer., ISBN 9783540162933, xv, 111
Book
1981, CRC series on experiences in clinical oncology, ISBN 9780849357312, 294
Book
1981, ISBN 9780849357312, 294
Book
1980, ISBN 9780893520922, xi, 465
Book
1989, Current treatment of cancer., ISBN 9783540505952, xvi, 287
Book
1989, ISBN 9783540505952, xvi, 287
Book
1983, ISBN 0849357330, 2 v.
Book
Tijdschrift voor Theologie, ISSN 0168-9959, 01/1980, Volume 20, Issue 1, p. 40
Journal Article
American Journal of Clinical Oncology, ISSN 0277-3732, 02/1982, Volume 5, Issue 1, pp. 13 - 20
Journal Article
American Journal of Clinical Oncology: Cancer Clinical Trials, ISSN 0277-3732, 1982, Volume 5, Issue 1, pp. 13 - 19
Multiple myeloma is one of the few malignancies with a distinct tumor marker, the myeloma protein. This marker, as well as other disease manifestations, can be... 
ONCOLOGY | Cyclophosphamide - administration & dosage | Melphalan - administration & dosage | Multiple Myeloma - drug therapy | Multiple Myeloma - pathology | Prognosis | Multiple Myeloma - diagnosis | Humans | Antineoplastic Agents - administration & dosage | Drug Therapy, Combination | Neoplasm Staging
Journal Article
Cancer Research, ISSN 0008-5472, 1980, Volume 40, Issue 4, pp. 1062 - 1065
Journal Article
JNCI: Journal of the National Cancer Institute, ISSN 0027-8874, 04/1978, Volume 60, Issue 4, pp. 731 - 736
Journal Article
Cancer, ISSN 0008-543X, 04/1981, Volume 47, Issue 8, pp. 1959 - 1962
ICRF‐187 (NSC‐169780), the (+) enantiomer of the racemic antineoplastic agent ICRF‐159 (NSC‐129943), was administered intravenously for five days every three... 
Journal Article
Cancer, ISSN 0008-543X, 11/1984, Volume 54, Issue 10, pp. 2248 - 2256
The Southwest Oncology Group has completed a study of 213 women with the first recurrence of breast cancer. Eligibility included a radical or modified radical... 
Journal Article
Journal of Chronic Diseases, ISSN 0021-9681, 03/1962, Volume 15, Issue 3, pp. 269 - 272
Journal Article
Cancer, ISSN 0008-543X, 08/1982, Volume 50, Issue 3, pp. 423 - 434
The Southwest Oncology Group in a prospective randomized study compared one year of adjuvant combination chemotherapy with continuous CMFVP to two years of... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.